RUNX1 has been reported to be a driver in cancer types (Wu et al., 2015) and a member of the Runt family, RUNX3, has been found to have an oncogenic role in head and neck cancer (Kudo et al., 2011). This evidence concerns the gene RUNX3 and head and neck cancer.